Divided Panel Won’t Rehear Dispute Over Patented MS Treatment
WASHINGTON, D.C. — In a March 16 order, the Federal Circuit U.S. Court of Appeals said it will not revisit a November holding that declared a patented method for treating multiple...To view the full article, register now.
Already a subscriber? Click here to view full article